Clinical activity of the anti-CD19 bite (R) blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL): Interim results of a phase II study
2011
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
9
Citations
NaN
KQI